346 related articles for article (PubMed ID: 28321605)
21. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
[TBL] [Abstract][Full Text] [Related]
22. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder.
Kim BN; Lee JS; Cho SC; Lee DS
Yonsei Med J; 2001 Feb; 42(1):19-29. PubMed ID: 11293498
[TBL] [Abstract][Full Text] [Related]
23. A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response.
Schweitzer JB; Lee DO; Hanford RB; Tagamets MA; Hoffman JM; Grafton ST; Kilts CD
Neuropsychopharmacology; 2003 May; 28(5):967-73. PubMed ID: 12700698
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for more than 3 years' duration of central stimulant treatment in adult attention-deficit/hyperactivity disorder: a retrospective, naturalistic study.
Torgersen T; Gjervan B; Nordahl HM; Rasmussen K
J Clin Psychopharmacol; 2012 Oct; 32(5):645-52. PubMed ID: 22926598
[TBL] [Abstract][Full Text] [Related]
25. Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study.
Hammerness P; Biederman J; Petty C; Henin A; Moore CM
CNS Neurosci Ther; 2012 Jan; 18(1):34-40. PubMed ID: 21143432
[TBL] [Abstract][Full Text] [Related]
26. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
[TBL] [Abstract][Full Text] [Related]
27. Effects of a single-dose methylphenidate challenge on resting-state functional connectivity in stimulant-treatment naive children and adults with ADHD.
Kaiser A; Broeder C; Cohen JR; Douw L; Reneman L; Schrantee A
Hum Brain Mapp; 2022 Oct; 43(15):4664-4675. PubMed ID: 35781371
[TBL] [Abstract][Full Text] [Related]
28. ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD.
Epstein JN; Casey BJ; Tonev ST; Davidson MC; Reiss AL; Garrett A; Hinshaw SP; Greenhill LL; Glover G; Shafritz KM; Vitolo A; Kotler LA; Jarrett MA; Spicer J
J Child Psychol Psychiatry; 2007 Sep; 48(9):899-913. PubMed ID: 17714375
[TBL] [Abstract][Full Text] [Related]
29. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
Cho SC; Hwang JW; Kim BN; Lee HY; Kim HW; Lee JS; Shin MS; Lee DS
J Psychiatr Res; 2007 Sep; 41(6):459-65. PubMed ID: 16839567
[TBL] [Abstract][Full Text] [Related]
30. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
Golubchik P; Kodesh A; Weizman A
Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
[TBL] [Abstract][Full Text] [Related]
31. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.
Hechtman L; Greenfield B
Paediatr Drugs; 2003; 5(12):787-94. PubMed ID: 14658920
[TBL] [Abstract][Full Text] [Related]
32. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
33. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
[TBL] [Abstract][Full Text] [Related]
34. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
Volkow ND; Wang GJ; Tomasi D; Kollins SH; Wigal TL; Newcorn JH; Telang FW; Fowler JS; Logan J; Wong CT; Swanson JM
J Neurosci; 2012 Jan; 32(3):841-9. PubMed ID: 22262882
[TBL] [Abstract][Full Text] [Related]
35. Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day.
Günther T; Kahraman-Lanzerath B; Knospe EL; Herpertz-Dahlmann B; Konrad K
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):131-8. PubMed ID: 22364402
[TBL] [Abstract][Full Text] [Related]
36. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
[TBL] [Abstract][Full Text] [Related]
37. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
[TBL] [Abstract][Full Text] [Related]
38. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
Bange F; Le Heuzey MF; Acquaviva E; Delorme R; Mouren MC
Arch Pediatr; 2014 Jan; 21(1):108-12. PubMed ID: 24309201
[TBL] [Abstract][Full Text] [Related]
39. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
Rosa-Neto P; Lou HC; Cumming P; Pryds O; Karrebaek H; Lunding J; Gjedde A
Neuroimage; 2005 Apr; 25(3):868-76. PubMed ID: 15808987
[TBL] [Abstract][Full Text] [Related]
40. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
